J. Goldman & Co LP

Position in DERM — Journey Medical Corp

CIK 1412741 NEW YORK, NY

Position in DERM

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$2,345,881

-$3,809,520 QoQ

Shares Held

500,188

-37.3% QoQ

Ownership

1.82%

of shares outstanding

% of Portfolio

0.12%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

J. Goldman & Co LP holds $5,272,240 across 4 Drug Manufacturers - Specialty & Generic names. DERM ranks #1 (44.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DERM	Journey Medical Corp This page	500,188	$2,345,881
2	PCRX	Pacira BioSciences, Inc.	97,772	$2,209,647
3	LQDA	Liquidia Corp	12,012	$453,332
4	CPIX	Cumberland Pharmaceuticals Inc	81,040	$263,380

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,345,881	500,188	-37.3%	Shares	Sole	2026-05-15
2025-12-31	$6,155,401	798,366	—	Shares	Sole	2026-02-17
No filing history on record for this holder in this stock.